Actos Bladder Cancer Spurs Lawsuits
Charles Pulikowski | January 23rd, 2012
Since the launch of Actos in 1999, many patients with type 2 diabetes have used this medication to control their blood sugar levels. However, over the years, a frightening Actos side effect has come to light: an increased risk of Actos bladder cancer. Many Actos users have developed bladder cancer over the past decade, and a recent study done in France showed that Actos users have a 22 percent higher risk for bladder cancer than users of other TZD drugs. As a result of that study, France banned Actos, and Germany suspended sales of the medication.
Here in the U.S., Actos remains on the market. But in June of 2011, the FDA issued a public health warning stating that patients taking the drug for longer than a year may experience a higher risk of bladder cancer, and a month later, on July 14, 2011, the FDA issued a mandate requiring the drug’s manufacturer, Takeda Pharmaceuticals, to post a warning about the risk of bladder cancer resulting from Actos on Actos medication labels.
These new developments, confirming that using Actos does bring an increased risk of bladder cancer, is spurring the filing of lawsuits from plaintiffs who have suffered Actos bladder cancer after using the drug. These plaintiffs are seeking settlements to compensate them and their families for medical bills, loss of income, and pain and suffering due to this terrible disease.
Individual Details of Actos Lawsuits
One such plaintiff seeking a compensation for Actos claims is Ronald Vanord of New York. Vanord took Actos for 12 years, beginning in 1999 shortly after the drug hit the market. He subsequently developed bladder cancer, but continued to take the drug until October of 2011. He is seeking an Actos settlement of more than $75,000 for compensatory and punitive damages, and he and his wife are also suing for loss of consortium.
Another plaintiff, Helen Olah of Georgia, began taking Actos in 2003, and was diagnosed with bladder cancer after seven years on the drug. Her lawsuit, like Vanord’s, alleges that Takeda knew of the risks but deliberately concealed them from doctors and patients. Olah is also seeking an Actos settlement of more than $75,000. Vanord and Olah join many other plaintiffs who have filed lawsuits against Takeda and are seeking Actos settlements after suffering Actos bladder cancer.
Since these Actos lawsuits are new, it is too soon to tell what type of settlements will be obtained.
- Actos Bladder Cancer Spurs Lawsuits
- Bladder Cancer Lawsuits Filed Against Actos Manufacturer
- Actos Lawsuit Filed in Georgia by Woman Who Suffers from Bladder Cancer